Most Read Articles
16 Apr 2016
New drug applications approved by US FDA as of 1 - 15 Apr 2016 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
Audrey Abella, 15 Oct 2018
Reducing salt intake is one of the most practical ways to help tackle hypertension, according to data presented at AFCC 2018.

QTc prolongation uncommon in critically ill patients using quetiapine

15 Jun 2018

Use of quetiapine among critically ill patients rarely leads to corrected QT (QTc) interval prolongation, reports a new study.

“Patients receiving concomitant medications known to prolong the QTc interval may be at an increased risk,” the authors said.

A total of 103 patients were enrolled in the analysis during the study period. Fourteen (13.6 percent) patients had QTc interval prolongation >60 ms. The median change in QTc interval was 20 ms.

No incidence of Torsades de Pointes (TdP), a form of polymorphic ventricular tachycardia in patients with a long QT interval, was reported. Multivariable analysis revealed that administration of a concomitant medication known to prolong the QTc interval was the only variable correlated with higher incidence of QTc prolongation (p=0.046).

This single-centre, prospective cohort analysis involved intensive care unit (ICU) patients receiving quetiapine between October 2015 and February 2016 to describe the impact of the study drug on QTc interval prolongation in critically ill patients.

The primary endpoint was the incidence of QTc prolongation >60 ms above baseline during therapy. Minor endpoints were median change in QTc interval and incidence of TdP. Variables associated with greater risk of QTc prolongation were determined by means of univariate and multivariable analyses.

“Quetiapine, an atypical antipsychotic used in the ICU to manage delirium, has a possible adverse effect of QTc interval prolongation,” the authors said.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
16 Apr 2016
New drug applications approved by US FDA as of 1 - 15 Apr 2016 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
Audrey Abella, 15 Oct 2018
Reducing salt intake is one of the most practical ways to help tackle hypertension, according to data presented at AFCC 2018.